Category Archives: Cancer and neoplasms
Cancer and neoplasms
In a Securities and Exchange Commission (SEC) filing last Friday, US oncology focused biotech Syros Pharmaceuticals (Nasdaq: SYRS) disclosed it has received notice from Incyte Corp (Nasdaq: INCY) that it was opting out of a blood cancer treatment collaboration dated January 2018, on novel therapies for myeloproliferative neoplasms. Syros’ shares closed up 1.6% at $3.82 following the announcement, which comes just a couple of weeks after US pharma…
In a Securities and Exchange Commission (SEC) filing last Friday, US oncology focused biotech Syros Pharmaceuticals (Nasdaq: SYRS) disclosed it has received notice from Incyte Corp (Nasdaq: INCY) that it was opting out of a blood cancer treatment collaboration dated January 2018, on novel therapies for myeloproliferative neoplasms. Syros’ shares closed up 1.6% at $3.82 […]
Cancer and neoplasms
Advocacy, Education of Individuals With Myeloproliferative Neoplasms Are Important to Support Patient Engagement, Outcomes
Aug
Patients with hematologic myeloproliferative neoplasms (MPNs)—a group of rare blood diseases that include primary myelofibrosis, essential thrombocythemia (ET), and polycythemia vera (PV)—should be more active in their treatment plan, according to experts in oncology pharmacy who participated in a Pharmacy Times clinical forum in Chicago, Illinois, in June 2023. “Our role as pharmacists is to […]
Incyte decided not to advance its blood cancer collaboration with Syros Pharmaceuticals in another blow to the biotech’s partnership portfolio. Incyte gave notice Aug. 9 that it would end its myeloproliferative neoplasms partnership with the Cambridge, MA-based biotech within 60 days. According to an SEC filing on Aug. 11, Syros said “Incyte exercised its right […]
Aug
Filippos Kyriakidis,1,* Dionysios Kogias,2,* Theodora Maria Venou,1,* Eleni Karlafti,3,4 Daniel Paramythiotis5 1Second Chemotherapy Department, Theagenio Cancer Hospital of Thessaloniki, Thessaloniki, Greece; 2First Department of Internal Medicine, University General Hospital of Alexandroupolis, Alexandroupolis, Greece; 3Emergency Department, AHEPA General University Hospital, Aristotle University of Thessaloniki, Thessaloniki, Greece; 4First Propaedeutic Department of Internal Medicine, University General Hospital of […]
Aug
Thyroid nodules are one of the most prevalent endocrine system diseases. Studies have shown that about 70% of the population worldwide have thyroid nodules, most benign and malignant nodules account for approximately 10%-15%.1–3 Ultrasound imaging is simple and rapid with high resolution. Its value in detecting and evaluating thyroid nodules has gradually been recognized in […]
Aug
Doctors said because of the tumour, the woman could not eat and weighed just 49 kg New Delhi: Doctors in Indore have successfully removed a whopping 15 kg tumour from the stomach of a woman, who constantly complained of pain and discomfort. According to doctors at the Index Hospital, a more than two-hour surgery was […]
Cancer and neoplasms
Selective COX-2 inhibitors do not increase gastrointestinal reactions after colorectal cancer surgery: a systematic review and meta-analysis
Aug
Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394–424. https://doi.org/10.3322/caac.21492. Epub 2018 Sep 12. Erratum in: CA Cancer J Clin. 2020;70(4):313. Article PubMed Google Scholar Douillard JY, Cunningham D, Roth […]
Cancer and neoplasms
Awareness of head and neck cancer among patients attended at a regional referral hospital in Tanzania
Aug
Socio-demographic characteristics of the respondents In this study, a total of 315 respondents were recruited where majority were from rural area, 175(55.6%) while those from urban area were 140(44.4%) respondents. Males, 209 (66.3%) predominated in this study and females were 106 (33.7%) (M: F = 1.94:1). Majority of the respondents belonged to the age group, 18– 33 years […]